Journals / Retina-Vitreus / 2020 / Cilt: 29 - Sayı: 2

Anti-Angiogenic Effect of Matrine in in-Vivo ROP-Mouse- Model

Pages
178–186
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The incidence of mitochondrial dysmorphology andapoptosis were lower in groups receiving Mat compared to the control groups.Conclusion: Mat seems to suppress REP and has anti-apoptotic activity in the HIR mouse model.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the effect of intravitreal (IV) Matrine (Mat) injection on retinal endothelial cell proliferation (REP), retinal morphology,and apoptotic activity in hyperoxia induced (HIR) in-Vivo ROP- mouse model using C57BL/6J.Methods: Total of 48 C57BL/6J mice were divided in 6 group each including 8.
📊
Key Findings & Data:Group A and B-S exposed to room air were negative controlgroups; group C, D-S, E and F exposed to 75% ± 2% oxygen from postnatal day (PD) 7 to PD 12 comprised HIR groups.
💡
Conclusion & Impact:The incidence of mitochondrial dysmorphology andapoptosis were lower in groups receiving Mat compared to the control groups.Conclusion: Mat seems to suppress REP and has anti-apoptotic activity in the HIR mouse model.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: To evaluate the effect of intravitreal (IV) Matrine (Mat) injection on retinal endothelial cell proliferation (REP), retinal morphology,and apoptotic activity in hyperoxia induced (HIR) in-Vivo ROP- mouse model using C57BL/6J.Methods: Total of 48 C57BL/6J mice were divided in 6 group each including 8. Group A and B-S exposed to room air were negative controlgroups; group C, D-S, E and F exposed to 75% ± 2% oxygen from postnatal day (PD) 7 to PD 12 comprised HIR groups. Group C and D-S werecontrol groups, group E and F were low and high dose IV-Mat injected groups. Group A and C received no IV injection, B-S and D-S received 1μL IV sterile 0.9% NaCl injection, E and F received 0.78μg and 6.25μg IV-Mat injection respectively. After enucleation, we measured REP bycounting neovascular tufts in cross-sections and examined histological, ultrastructural changes via light and transmission electron microscope.Apoptosis was detected using terminal deoxynucleotidyl transferase-mediated nick end-labeling.Results: No REP was detected in negative control groups. REP levels were signifi cantly different between low- and high-dose Mat groups.REP levels were signifi cantly lower in the Mat groups, compared to the control groups. The incidence of mitochondrial dysmorphology andapoptosis were lower in groups receiving Mat compared to the control groups.Conclusion: Mat seems to suppress REP and has anti-apoptotic activity in the HIR mouse model.

🔖

Cite This Article

ÇELEBİ, N., HELVACIOĞLU, F., HABERAL, N., DAĞDEVİREN, A., BACANLI, D., OTO, S., YILMAZ, G., AKKOYUN, İ. (2020). Anti-Angiogenic Effect of Matrine in in-Vivo ROP-Mouse- Model. Retina-Vitreus, Cilt: 29 - Sayı: 2, 178–186. https://ajindex.com/articles/340345

References (1)

  1. Tolentino MS, Tolentino AJ, Tolentino MJ (2016) Current and investigational drugs for the treatment of diabetic retinopathy. Expert Opin Investig Drugs 25:1011-1022 2- Rivera JC, Holm M, Austeng D et al. (2017) Retinopathy of prematurity: infl ammation, choroidal degeneration, and novel promising therapeutic strategies. J Neuroinfl ammation 14:165 3- Stahl A, Krohne TU, Eter N et al. (2018) Comparing Alternative Ranibizumab Dosages for Safety and Effi cacy in Retinopathy of Prematurity: A Randomized Clinical Trial. JAMA Pediatr 172:278-286 4- Mintz-Hittner HA, Kennedy KA, Chuang AZ et al. (2011) Effi cacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603-615 5- Bao J, Lv Z, Wang S (2018) Anti-angiogenic effect of Interleukin-26 in oxygen-induced retinopathy mice via inhibiting NFATc1-VEGF pathway. Biochem Biophys Res Commun 499:849-855 6- Zhao P, Zhou R, Zhu XY et al. (2015) Matrine attenuates focal cerebral ischemic injury by improving antioxidant activity and inhibiting apoptosis in mice. Int J Mol Med 36:633-644 7- Yu J, Yang S, Wang X et al. (2014) Matrine improved the function of heart failure in rats via inhibiting apoptosis and blocking beta3adrenoreceptor/endothelial nitric oxide synthase pathway. Mol Med Rep 10:3199-3204 8- Wang J, Tang Z, Zhang Y et al. (2019) Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity. Eur J Pharmacol 842:118-124 9- Smith LE, Wesolowski E, Mclellan A et al. (1994) Oxygeninduced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111 10- Akkoyun I, Karabay G, Haberal N et al. (2012) Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol 90:564-570 11- Stahl A, Chen J, Sapieha P et al. (2010) Postnatal weight gain modifi es severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177:2715-2723 12- Smith LE, Shen W, Perruzzi C et al. (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5:1390-1395 13- Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT (1996). Subcutaneous injection of acyclicpeptideantagonistof vitronectin receptor-type integrinsinhibitsretinal neovascularization. Nat Med2:529-33. 14- Folkman J (2007) Angiogenesis: an organizing principle for drug